Af­ter Lil­ly com­plaint, No­var­tis pulls claim in DTC can­cer drug ad

No­var­tis has pulled a claim from a di­rect-to-con­sumer ad for its breast can­cer treat­ment Kisqali af­ter the Na­tion­al Ad­ver­tis­ing Di­vi­sion of BBB Na­tion­al Pro­grams said …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER